Armstrong reports on early results from first-ever gene therapy in wound healing study at vascular biology symposium @USC @ResearchatUSC @USC_vascular

David G. Armstrong, Professor of Surgery and Director of the Southwestern Academic Limb Salvage Alliance (SALSA) at Keck School of Medicine of University of Southern California (USC), reported on the first results of a novel phase 2 study of gene therapy to heal wounds and reduce amputations in people with vascular disease at the International Vascular Biology Meeting (IVBM), held in Oakland, California this past weekend. The study, which consists of injecting fragments of a virus into muscle, may help grow blood vessels and improve circulation, thereby increasing the chances of healing. The study, which is currently 90% enrolled, is expected to have its final results available some time next year. Armstrong became the first podiatric surgeon ever to speak to this group.

David G. Armstrong, Professor of Surgery and Ei Yamada, PhD, CEO of AnGes, Japan, prior to session on gene therapy

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Up ↑

%d bloggers like this: